In an unusual twist of corporate he-said-she-said, cannabis giants Curaleaf Holdings and Flora Growth have found themselves embroiled in a public dispute about the nature—and even the existence—of a supply agreement between the two companies.
While Flora Growth has most recently affirmed a new supply agreement to distribute medical cannabis products in Germany, the back-and-forth has played out on social media, leaving investors and the cannabis industry scratching their heads and wondering just what kind of partnership these two companies actually have.
The saga began on October 30, when Flora Growth released an announcement about a supply agreement with Curaleaf to "target [the] $450 Million German cannabis market." The post suggested a partnership that would see Curaleaf supplying cannabis products to Flora for distribution in Germany, where Flora is expanding its presence in the rapidly growing cannabis market.
Curaleaf, however, quickly poured cold water on this optimistic narrative. The company's official X account responded, bluntly denying any deal: "There is no agreement in place between Curaleaf and Flora Growth Corp."
Read more at The Deep Dive